Delayre-Orthez C, de Blay F, Frossard N, Pons F
Inflammation et environnement dans l'asthme, Faculté de Pharmacie, Université Louis Pasteur-Strasbourg I, Illkirch, France.
Clin Exp Allergy. 2004 Nov;34(11):1789-95. doi: 10.1111/j.1365-2222.2004.02082.x.
Levels of endotoxins greatly differ according to environmental settings.
To study the effect of lipopolysaccharide (LPS) at increasing doses (0.1-1000 ng) on allergen sensitization and challenge in the mouse.
Mice were sensitized systemically and challenged locally with ovalbumin (OVA) in the presence or absence of LPS. Inflammation was assessed by determining total and differential cell counts and T-helper type 2 (Th)2 cytokine (IL-4 and IL-5) levels in bronchoalveolar lavage fluid (BALF). Total and OVA-specific IgE levels were quantified in serum. Airway hyper-responsiveness (AHR) was assessed by whole-body barometric plethysmography.
Administered prior to sensitization, LPS at 100 or 1000 ng dose-dependently decreased allergen- induced total and OVA-specific IgE, airway eosinophilia and Th2 cytokines in BALF, without changing AHR. Administered during OVA challenge, LPS at 1 ng (an infra-clinical dose) or 100 ng (a dose triggering neutrophilia) enhanced airway eosinophilia, without affecting IgE levels or AHR.
Our data clearly demonstrate that exposure to LPS influences allergen-induced IgE production and airway eosinophilia in a time and dose-dependent manner, preventing IgE production and development of eosinophilia when administered during allergen sensitization at high doses, and inducing exacerbation of eosinophilia when administered upon allergen challenge at low doses, including infra-clinical doses.
内毒素水平因环境设置差异很大。
研究递增剂量(0.1 - 1000 ng)的脂多糖(LPS)对小鼠变应原致敏和激发的影响。
在有或无LPS存在的情况下,用卵清蛋白(OVA)对小鼠进行全身致敏和局部激发。通过测定支气管肺泡灌洗液(BALF)中的总细胞计数和分类细胞计数以及2型辅助性T细胞(Th)2细胞因子(IL - 4和IL - 5)水平来评估炎症。对血清中的总IgE和OVA特异性IgE水平进行定量。通过全身气压容积描记法评估气道高反应性(AHR)。
在致敏前给予LPS,100或1000 ng剂量的LPS剂量依赖性地降低变应原诱导的总IgE和OVA特异性IgE、气道嗜酸性粒细胞增多以及BALF中的Th2细胞因子,而不改变AHR。在OVA激发期间给予LPS,1 ng(亚临床剂量)或100 ng(引发中性粒细胞增多的剂量)的LPS增强气道嗜酸性粒细胞增多,而不影响IgE水平或AHR。
我们的数据清楚地表明,暴露于LPS以时间和剂量依赖性方式影响变应原诱导的IgE产生和气道嗜酸性粒细胞增多,在高剂量变应原致敏期间给予LPS时可预防IgE产生和嗜酸性粒细胞增多的发展,而在低剂量变应原激发时给予LPS,包括亚临床剂量,可诱导嗜酸性粒细胞增多加剧。